Contact Musheng

Speaking Engagements

  

Maximize the Clinical & Commercial Opportunity of the Adenosine-Pathway as a Second-Generation Immuno-Oncology Target A plethora of showstopping clinical trial data readouts are being met with refreshed excitement, enthusiasm and R&D investment for adenosine-pathway targets, one of the most validated and established oncology pathways.

10-12 May 2022
  

Next Generation Protein Therapeutics Summit is excited to announce a brand new pre-conference workshop day plus a new main conference day to the 2023 agenda.

18-21 September 2023